Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells-Reference-Cited by-同舟云学术

Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells

Published:2022-07 Issue: Volume:347 Page:521-532
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Patel Savan K.,Billingsley Margaret M.,Frazee Caitlin,Han Xuexiang,Swingle Kelsey L.,Qin Jingya,Alameh Mohamad-Gabriel,Wang Karin,Weissman Drew,Mitchell Michael J.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference85 articles.

1. Infliximab for the treatment of plaque psoriasis;Gall;Biol. Targets Ther.,2008

2. CAR T cell immunotherapy for human cancer;June;Science.,2018

3. Challenges in assessing solid tumor responses to immunotherapy;Chai;Cancer Gene Ther.,2020

4. A review of Cancer immunotherapy toxicity II: adoptive cellular therapies, kinase inhibitors, monoclonal antibodies, and oncolytic viruses;Chhabra;J. Med. Toxicol.,2021

5. Genetically engineered T cells for cancer immunotherapy;Li;Signal Transduct. Target. Ther.,2019

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the design and delivery of RNA vaccines for infectious diseases;Advanced Drug Delivery Reviews;2024-10

2. Current landscape of mRNA technologies and delivery systems for new modality therapeutics;Journal of Biomedical Science;2024-09-10

3. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07

4. Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer;International Journal of Nanomedicine;2024-07

5. Steering the course of CAR T cell therapy with lipid nanoparticles;Journal of Nanobiotechnology;2024-06-28